Abstract:CBF beta was recently found to be a key regulator of the ability of human immunodeficiency virus type 1 (HIV-1) Vif to overcome host antiviral APOBEC3 proteins. However, the detailed molecular requirements for the Vif-CBF beta interaction are still not clear. Here, we mapped the minimum Vif domain required for CBF beta binding. In terms of CBF beta binding, the Vif N terminus was very sensitive to deletions. We determined that the Vif fragment from residues 5 to 126 was sufficient to form a stable complex with CBF beta in vitro. We also observed that ionic interactions were not the main contributor to the interaction between Vif and CBF beta. Instead, hydrophobic interactions were important for maintaining the Vif-CBF beta complex, since it could be disrupted by nonionic detergent. Site-directed mutagenesis of conserved hydrophobic amino acids revealed novel residues in Vif that were important for CBF beta binding and APOBEC3 inactivation. At least part of the well-characterized HCCH domain (residues 108 to 139) was required to form a stable Vif-CBF beta complex. Thus, the HCCH motif may have a dual role in binding both Cul5 and CBF beta. Considering the importance of Vif in HIV-1 infection, this unique Vif-CBF beta interaction represents an attractive pharmacological intervention target against HIV-1. IMPORTANCE Vif-induced APOBEC3 protein degradation was the first host antiviral mechanism against HIV-1/simian immunodeficiency virus to be revealed, yet details regarding which proteins are degraded are not fully demonstrated. Recently, host cellular factor CBF beta was found to be essential for Vif to function and promote viral infectivity. In this study, we present more critical information on the Vif-CBF beta interaction by revealing that hydrophobicity contributes the most to the Vif-CBF beta interaction and locating several novel hydrophobic sites (tryptophans and phenylalanines) that are conserved among Vif proteins from different lentiviruses and essential for Vif binding to CBF beta. Mutations on these sites result in a reduced/abolished Vif-CBF beta interaction, leading to the attenuated potency of Vif on both inducing the degradation of antiviral factors like APOBEC3G and promoting HIV-1 infectivity. Therefore, information from this study will help people to further understand how Vif acts against host antiviral mechanism, which is important for novel anti-HIV-1 drug development.

Moloney Leukemia Virus 10 (MOV10) Inhibits the Degradation of APOBEC3G Through Interference with the Vif-mediated Ubiquitin–proteasome Pathway

Host MOV10 is Induced to Restrict Herpes Simplex Virus 1 Lytic Infection by Promoting Type I Interferon Response.

APOBEC3G Inhibits MicroRNA-mediated Repression of Translation by Interfering with the Interaction between Argonaute-2 and MOV10

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein

RNA Helicase MOV10 Functions As a Co-Factor of HIV-1 Rev to Facilitate Rev/RRE-dependent Nuclear Export of Viral Mrnas.

A Naturally Occurring Vif Mutant (I107T) Attenuates Anti-Apobec3g Activity and HIV-1 Replication.

Conserved and Non-Conserved Features of HIV-1 and SIVagm Vif Mediated Suppression of APOBEC3 Cytidine Deaminases.

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

Vif Hijacks CBF-β to Degrade APOBEC3G and Promote HIV-1 Infection

Characterization Of Conserved Motifs In Hiv-1 Vif Required For Apobec3g And Apobec3f Interaction

MOV10 interacts with Enterovirus 71 genomic 5'UTR and modulates viral replication.

Regulation of Apobec3f and Human Immunodeficiency Virus Type 1 Vif by Vif-Cul5-Elonb/C E3 Ubiquitin Ligase

Structural basis of suppression of host translation termination by Moloney Murine Leukemia Virus

Identification of an Hiv-1 Replication Inhibitor Which Rescues Host Restriction Factor Apobec3g in Vif-Apobec3g Complex

Influence Of Primate Lentiviral Vif And Proteasome Inhibitors On Human Immunodeficiency Virus Type 1 Virion Packaging Of Apobec3g

HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain

The structural basis for HIV-1 Vif antagonism of human APOBEC3G

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms

Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.